• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
CAO Hongyan,ZHAO Jie,CHAI Fayong,ZHANG Jie,BAI Jianxue.Quality risks analysis on the GMP compliance inspections requested by pharmaceutical enterprises in Shandong Province[J].Journal Of Pharmaceutical Research,2023,42(10):844-848[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2646times   Download 2811次 QR Code for this article
Scan with your phone!
山东省依企业申请药品生产质量管理规范符合性检查质量风险分析
曹鸿雁,赵杰,柴发永,张杰,柏建学
Font:Larger+|Default|Smaller-
(山东省食品药品审评查验中心,山东 济南 250014)
摘要:
通过归纳法律法规对药品生产质量管理规范符合性检查的要求,统计分析2021年和2022年山东省承担的依企业申请开展的药品生产质量管理规范符合性检查情况发现,企业申请检查情形较为复杂,在质量管理、生产管理、确认与验证、数据管理等方面还存在质量风险。药品生产企业需关注在生产质量管理方面存在的薄弱环节,落实持有人主体责任,持续提升执行GMP的规范性和水平;监管部门需明确不同情形检查要点,科学高效开展现场检查。
关键词:  药品生产质量管理规范  符合性检查  检查情形  缺陷项目  质量风险
DOI:10.13506/j.cnki.jpr.2023.10.018
基金项目:
Quality risks analysis on the GMP compliance inspections requested by pharmaceutical enterprises in Shandong Province
CAO Hongyan,ZHAO Jie,CHAI Fayong,ZHANG Jie,BAI Jianxue
(Shandong Center For Food and Drug Evaluation & Inspection,Jinan250014,China)
Abstract:
By summarizing the requirements of laws and regulations for GMP compliance inspections, and statistically analyzing the various situations of GMP compliance inspections requested by pharmaceutical enterprises in Shandong province in 2021 and 2022, we find that the requests are relatively complex, and there are quality risks in quality management, production management, qualification and validation, data management, and other aspects. Pharmaceutical enterprises should pay much attention to the weaknesses in the quality management, fulfill their own duties as MAH holders, and continuously improve the GMP compliance level; Regulatory authorities should clarify key inspection points for different GMP compliance requests, and conduct on-site inspections scientifically and efficiently.
Key words:  GMP  Compliance inspection  Inspection situations  Defective items  Quality risk
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.